These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18452581)
1. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. Yu P; Passam FH; Yu DM; Denyer G; Krilis SA J Thromb Haemost; 2008 Jul; 6(7):1215-23. PubMed ID: 18452581 [TBL] [Abstract][Full Text] [Related]
2. β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase. Chiu WC; Chiou TJ; Chung MJ; Chiang AN PLoS One; 2016; 11(8):e0161950. PubMed ID: 27579889 [TBL] [Abstract][Full Text] [Related]
3. β₂-glycoprotein I inhibits VEGF-induced endothelial cell growth and migration via suppressing phosphorylation of VEGFR2, ERK1/2, and Akt. Chiu WC; Lin JY; Lee TS; You LR; Chiang AN Mol Cell Biochem; 2013 Jan; 372(1-2):9-15. PubMed ID: 22956423 [TBL] [Abstract][Full Text] [Related]
4. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516 [TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Hata Y; Rook SL; Aiello LP Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422 [TBL] [Abstract][Full Text] [Related]
6. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects. Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666 [TBL] [Abstract][Full Text] [Related]
7. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957 [TBL] [Abstract][Full Text] [Related]
8. Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells. Aoki S; Cho SH; Ono M; Kuwano T; Nakao S; Kuwano M; Nakagawa S; Gao JQ; Mayumi T; Shibuya M; Kobayashi M Anticancer Drugs; 2006 Mar; 17(3):269-78. PubMed ID: 16520655 [TBL] [Abstract][Full Text] [Related]
9. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032 [TBL] [Abstract][Full Text] [Related]
10. Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells. Lee HJ; Kim SA; Lee HJ; Jeong SJ; Han I; Jung JH; Lee EO; Zhu S; Chen CY; Kim SH PLoS One; 2010 Aug; 5(8):e12358. PubMed ID: 20808805 [TBL] [Abstract][Full Text] [Related]
11. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904 [TBL] [Abstract][Full Text] [Related]
12. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells. Tahir SA; Park S; Thompson TC Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922 [TBL] [Abstract][Full Text] [Related]
14. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling. Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610 [TBL] [Abstract][Full Text] [Related]
15. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect. Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043 [TBL] [Abstract][Full Text] [Related]
17. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways. Lee SH; Lee J; Jung MH; Lee YM Mol Nutr Food Res; 2013 Feb; 57(2):225-34. PubMed ID: 23229497 [TBL] [Abstract][Full Text] [Related]
18. Plasmin-clipped beta(2)-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27. Beecken WD; Ringel EM; Babica J; Oppermann E; Jonas D; Blaheta RA Cancer Lett; 2010 Oct; 296(2):160-7. PubMed ID: 20435405 [TBL] [Abstract][Full Text] [Related]
19. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo. Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585 [TBL] [Abstract][Full Text] [Related]
20. Changes of messenger RNA expression of angiogenic factors and related receptors during follicular development in gilts. Shimizu T; Jiang JY; Sasada H; Sato E Biol Reprod; 2002 Dec; 67(6):1846-52. PubMed ID: 12444062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]